Understanding Melanotan II
Melanotan II is a synthetic melanocortin agonist discussed for its effects on pigmentation and sexual function. Reported community practices should not be confused with established clinical protocols.
Compound Type
Synthetic melanocortin receptor agonist
Main Research Areas
Skin pigmentation and sexual effects
Mechanism
Acts on melanocortin receptors involved in pigmentation and other physiological responses.
Administration Context
Subcutaneous administration is described in community reports.
Evidence Level
Reported community practices do not establish a safe or effective tanning protocol.
Important Distinction
Increased pigmentation does not provide protection against UV-related skin damage.
Important Research Notice
Melanotan II-related pigmentation should not be considered a substitute for sunscreen, protective clothing, shade, or other established sun-protection measures.
Reported Loading and Maintenance Patterns
The following amounts describe community-reported practices from the reference document. They are not medically validated dosing instructions or recommendations.
SC example
Per administration
Frequency
Daily total
Reported cycle
Initial Loading
100–250 mcg/day
Days 1–3
100–250 mcg
3 days
Extended Loading
250–500 mcg/day, progressing to 500–1,000 mcg/day
Days 4–14, then weeks 3–6
250–1,000 mcg
Up to 6 weeks
Maintenance
250–1,000 mcg per administration
Once weekly or once/twice weekly
Not applicable – maintenance examples are weekly
Ongoing maintenance examples; no validated duration
Per administration
100–250 mcg/day
Per administration
250–500 mcg/day, progressing to 500–1,000 mcg/day
Frequency
Days 4–14, then weeks 3–6
Daily total
250–1,000 mcg
Reported cycle
Up to 6 weeks
Per administration
250–1,000 mcg per administration
Frequency
Once weekly or once/twice weekly
Daily total
Not applicable – maintenance examples are weekly
Reported cycle
Ongoing maintenance examples; no validated duration
These are reported community patterns only. They do not establish safe tanning, clinical effectiveness, or protection from UV injury.
Not a Validated Treatment Protocol
No community loading or maintenance schedule should be interpreted as a proven safe dose. Melanotan II use carries potential health risks and should be discussed with a qualified healthcare professional.
Safety Concerns and Possible Effects
Melanotan II has important safety concerns. Reported effects include nausea, flushing, changes in moles, and prolonged erections. The available information does not establish a reliable long-term safety profile.
Storage and Handling Considerations
Storage Conditions
The source describes cold and dark handling for mixed-vial products. Exact requirements depend on the specific product and its documentation.
Product Stability
Supplier stability claims require independent validation. No universal mixed-vial stability period is established in the source.
Monitoring
Skin lesions, pigmentation changes, and erectile symptoms are important concerns. Severe or persistent symptoms require medical review.
Product Quality
Research-vial products may have different quality and handling requirements. Do not assume that products from different suppliers are equivalent.
Example Concentration Calculations
These mathematical examples show how concentration and U-100 volume markings relate. They are not preparation, mixing, or administration instructions.
Amount (mg)
Final volume (mL)
Concentration (mg/mL)
Per 1 U (mcg)
Per 10 U (mcg)
10 mg
1 mL
10 mg/mL
100 mcg
1,000 mcg
10 mg
2 mL
5 mg/mL
50 mcg
500 mcg
Concentration (mg/mL)
10 mg/mL
Concentration (mg/mL)
5 mg/mL
U refers to a U-100 volume marking, where 1 U = 0.01 mL. These are calculation examples only, not instructions for mixing or administration.
Research Findings and Evidence Limitations
Melanotan II has been discussed in research involving pigmentation and sexual effects. Community tanning practices do not establish clinical safety or long-term benefit.
Pigmentation Effects
Melanotan II is associated with melanocortin activity and increased skin pigmentation. Pigmentation does not establish protection against UV-related skin damage.
Sexual Effects
Sexual effects have been discussed in connection with melanocortin receptor activity. Prolonged erections are an important reported safety concern.
Limited Safety Evidence
The source describes community practices but does not establish a validated long-term safety profile or a safe tanning protocol.
Regulatory and Research Disclaimer
Not an Approved General Tanning Treatment
Melanotan II should not be presented as an approved or established treatment for tanning. Community-reported schedules and supplier products do not establish regulatory approval, product quality, clinical effectiveness, or safety.
This page is provided for educational and research-information purposes only. It is not medical advice, a prescription, or a recommendation to use Melanotan II. Consult a qualified healthcare professional about health concerns.
